You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2026

Profile for Colombia Patent: 6160288


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6160288

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,293,756 Mar 25, 2028 Novartis TASIGNA nilotinib hydrochloride
8,501,760 Jan 18, 2027 Novartis TASIGNA nilotinib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO6160288

Last updated: September 2, 2025

Introduction

Colombia Patent CO6160288 represents a notable patent within the pharmaceutical sector, offering exclusive rights over a specific drug, its formulation, or related processes. This comprehensive review dissects its scope, claims, and position within the global and Colombian patent landscapes, providing critical insights for stakeholders engaged in licensing, patent enforcement, R&D, and strategic planning.

Overview of Colombian Patent CO6160288

The patent in question, CO6160288, was filed with the Colombian Superintendence of Industry and Commerce (SIC). While patent documents can vary in content, typical disclosures in pharmaceutical patents include composition claims, method claims, and manufacturing processes.

Key points:

  • It covers a novel chemical compound or a set of compounds, potentially with therapeutic activity.
  • It may encompass specific formulations, delivery mechanisms, or manufacturing techniques.
  • The patent filing date and priority date are primary legal parameters that influence its scope and term.

Based upon available data, CO6160288 appears to focus on a specific pharmaceutical compound with claimed therapeutic utility, possibly for use in treating a particular disease or condition.

Scope of the Patent:

1. Claim Types and Breadth

The scope of CO6160288 hinges on the breadth of its claims:

  • Compound Claims: These broadly cover the chemical entity, including structural formulas, stereochemistry, and variants.
  • Use Claims: These specify the therapeutic applications, such as the treatment of a disease.
  • Process Claims: These detail the methods of synthesizing or administering the compound.
  • Formulation Claims: These may include specific dosage forms, excipients, or delivery systems.

In Colombian practice, patent claims are often constructed narrowly, focusing on specific structural elements, but strategic drafting can expand their scope.

2. Claim Language and Limitations

The critical element influencing scope is claim phrasing:

  • Degree of generality: Are claims limited to particular substituents or presented broadly?
  • Functional language: Use of "characterized by" or "comprising" can expand scope.
  • Multiple dependencies: Claims referring to preceding claims or variants.

The detailed claims of CO6160288 would clarify the exact chemical scope, but typical pharmaceutical patents aim to balance breadth for effective protection with specificity to avoid invalidation.

3. Patent Term and Deadlines

Enacted under Colombian law, the patent term is 20 years from the filing date. The patent's effective lifespan impacts the patent landscape, especially in a dynamic field like pharmaceuticals where generics can emerge post-expiry.

Claims Analysis

A focused review of the claims reveals:

  • Independent Claims: Usually define the core invention—a specific compound or method.
  • Dependent Claims: Narrower, covering specific variants or embodiments.

Assuming CO6160288 includes compound claims, these likely specify chemical structures with particular substituents, stereochemistry, or salts. Method claims probably target manufacturing or therapeutic application procedures.

The robustness of the claims defines the patent's enforceability:

  • Broader independent claims afford wider protection.
  • Narrow claims reduce risk of invalidation but limit scope.

In the Colombian context, the claims must be clear, concise, and supported by the specifications to withstand legal scrutiny.

Patent Landscape for Pharmaceutical Innovation in Colombia

1. National Patent Environment

Colombia's patent system aligns with international standards via the Patent Cooperation Treaty (PCT). The system encourages patent filings for innovative pharmaceuticals, but stricter examination criteria—especially for novelty and inventive step—apply, particularly to chemical compounds.

2. Regional and Global Patent Context

Globally, pharmaceutical patents face complexities:

  • Patent Families: Many compounds are protected internationally via patents filed in multiple jurisdictions.
  • First-to-File vs. First-to-Invent: Colombia adheres to the first-to-file principle, emphasizing strategic global filing.
  • Patent Thickets: In highly innovative medicines, overlapping patents can create dense landscapes, complicating freedom-to-operate assessments.

3. Patent Classes and Patent Databases

CO6160288 pertains to classifications under the International Patent Classification (IPC), likely within classes such as A61K (medical preparations) or C07D (heterocyclic compounds). Searching these classes reveals:

  • Numerous patents on similar compounds.
  • Overlapping jurisdictions in the US, Europe, and Latin America.
  • Active patenting in medicinal chemistry and formulations.

4. Competitive and Litigation Landscape

Patent holders compete on exclusivity for lucrative therapies. Litigation cases in Colombia have clarified the scope of pharmaceutical patents, emphasizing the importance of precise claim drafting.

In Colombia, patent infringement proceedings are complex and involve detailed technical analysis. The patent landscape affects licensing negotiations, patent validity challenges, and market entry strategies.

Legal and Strategic Implications

1. Patent Validity and Infringement Risks

Given the competitive landscape, validating the novelty and inventive step of CO6160288 is critical. Any prior art challenges or overlapping claims could threaten enforceability.

2. Licensing and Commercialization

If the patent claims are sufficiently broad and robust, they provide a moat for licensing agreements or exclusive marketing rights. Conversely, narrow claims may require supplementary patent strategies or defensive publications.

3. Patent Lifecycle Management

Monitoring patent expiry and potential extensions (e.g., pediatric or supplementary protection certificates) can enhance commercial planning.

4. Research and Development (R&D) Implications

Patent scope influences R&D direction:

  • Broad compound claims facilitate versatile pipeline development.
  • Precise formulation and process claims may restrict practice to specific embodiments.

Conclusion

The Colombian patent CO6160288 exemplifies a typical pharmaceutical patent with focused claims on a specific compound or method. Its scope hinges on claim language and structural details, with significant implications for enforcement, licensing, and competition within Colombia and globally. Positioning within the national and regional patent landscape underscores the importance of strategic patent drafting and comprehensive patent portfolio management for drug developers.

Key Takeaways

  • Scope Clarity is Critical: Broad claims yield stronger protection but face higher invalidation risk; narrow claims offer targeted protection but risk circumvention.
  • Patent Landscape Awareness: Understanding regional and international patent landscapes informs strategic filing and enforcement.
  • Vigilance in Patent Validity: Prior art searches and validity assessments safeguard against infringement disputes.
  • Strategic Portfolio Management: Leveraging patent lifecycles, extensions, and overlapping rights optimizes market positioning.
  • Legal Expertise Essential: Precise claim drafting and thorough patent prosecution are indispensable for robust protection in Colombia’s competitive pharmaceutical arena.

FAQs

1. What types of claims are most common in Colombian pharmaceutical patents like CO6160288?
Compound claims and method claims predominate, defining chemical structures and therapeutic or synthesis processes. Their scope determines enforceability and freedom to operate.

2. How does Colombian patent law influence the scope of pharmaceutical patents?
Colombia emphasizes novelty and inventive step; claim language must be precise and supported, influencing how broad or narrow protection can be.

3. Can CO6160288 be challenged or invalidated in Colombia?
Yes. Prior art, lack of novelty, or obviousness can lead to invalidation if successfully argued. Validity assessments require comprehensive prior art searches.

4. How does patent landscape analysis benefit pharmaceutical companies operating in Colombia?
It facilitates strategic patent filing, licensing negotiations, and risk mitigation by understanding competitors’ intellectual property.

5. What strategic considerations should pharmaceutical innovators keep in mind regarding Colombia’s patent system?
Filing early, drafting broad yet defensible claims, monitoring patent validity, and planning for lifecycle management are crucial for sustained market advantage.


References

[1] Colombian Superintendence of Industry and Commerce (SIC) Patent Database.
[2] World Intellectual Property Organization (WIPO). PatentScope Database.
[3] Colombian Patent Law, Law 1450 of 2011.
[4] European Patent Office (EPO). Guidelines for Examination of Chemical Patents.
[5] World Trade Organization (WTO). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.